Daily price updates
What planify offer?
Join our channel partner program
₹1,790.00
Available in Depository:
NSDL
CDSL
Available for Investment:
Primary
Secondary
RECOMMENDATION
Neutral
Business Type
Near Leader
Management
Accounting Practice
Profitability
Solvency
Growth
Valuation
RATING
RECOMMENDATION
Neutral
Business Type
Near Leader
Here
are the Profit and Loss Statement and other details about the all Financial
Results of Martin & Harris
Laboratories Limited ending on 31st March 2021. Actual numbers and
more financial data including Total Assets, Total Shareholders fund, and all
the annual reports of the company. Also, get to know the Martin
and Harris Limited Share Price.
Higher than industry Revenue growth
Total Revenue has increased by 25.09% over the last 4 years v/s the 5 year industry average of 7.7%, the increased revenue is due to increased other income in FY21 by 471%
Higher than Industry Net Income
The net profit has increased by 57.23% as 4-year CAGR growth in FY21 v/s 5 years the industry average of 3.81%, the increase in net income of 1290% is primarily on account of FVTPL in FY21.
137.09
68.29
42.92
41.55
40.12
28.94
72.42
72.42
0.24
0
177.38
111.93
81.57
80.23
80.04
59.38
148.59
148.59
2.4
0.02
289.9
126.04
93.76
92.11
92.04
72.44
181.28
181.28
2.76
0.02
296.72
136.09
25.98
23.67
23.42
12.73
31.85
31.85
2.2
0.07
335.62
271.47
224.59
221.37
221.12
176.87
442.6
442.6
3.4
0.01
EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ Crores
* denotes current year's data
2018
Annual Report
2019
Annual Report
2020
Annual Report
2021
Annual Report
₹1,790.00
Available in Depository
NSDL
CDSL
Available for Investment
Primary
Secondary
Management
Accounting Practice
Profitability
Solvency
Growth
Valuation
